Premium
Salvage surgery for squamous cell carcinoma of the head and neck in the era of immunotherapy: Is it time to clarify our guidelines?
Author(s) -
Saba Nabil F.,
Mendenhall William M.,
Hutcheson Kate,
Suárez Carlos,
Wolf Greg,
Ferlito Alfio
Publication year - 2018
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.31717
Subject(s) - medicine , salvage surgery , head and neck , salvage therapy , immunotherapy , basal cell , surgery , head and neck squamous cell carcinoma , radiation therapy , head and neck cancer , oncology , cancer , chemotherapy
Is salvage surgery a 1‐size‐fits‐all approach? More importantly, in this era of improved systemic therapy, what arethe criteria according to which salvage surgery for squamous cell carcinoma of the head and neck should be the uncontested modality of choice?